Kier Group PLC
10 January 2005
10 January 2005
KIER SELLS A PFI EQUITY INVESTMENT
Kier Group plc has sold its 25.5% equity and loan stock interests in the Neath
Port Talbot Hospital concession to Secondary Market Infrastructure Fund UK LP.
Kier has received a cash consideration of £5.0m representing over twice the
value of the original investment in the project.
Kier Support Services will continue to provide non-clinical facilities
management services at the Hospital where it has a 30 year contract which
commenced in 2002.
Commenting, Kier Chief Executive, John Dodds said: "This sale demonstrates the
value of our PFI portfolio to shareholders which, after disposals, stands at a
committed book value of £16m.
"We remain committed to providing facilities management services to the Neath
Port Talbot Hospital and to continuing our long term relationship with the Bro
Morgannwg NHS Trust".
- ENDS -
For further information, please contact:
John Dodds, Chief Executive
Kier Group plc Tel: 01767 640111
Caroline Sturdy
Madano Partnership Tel: 020 7378 7033
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.